Biotech entity
pharma is the sole category represented across all 1 tracked stories. Graphenicalab is most often covered alongside Coherence Neuro, which appears in 1 of these 1 story. Graphenicalab appears in 1 tracked Biotech story from March 6, 2026. The tracked stories average 7 original sources each.
Last mentioned: Mar 6, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
pharma is the sole category represented across all 1 tracked stories. Graphenicalab is most often covered alongside Coherence Neuro, which appears in 1 of these 1 story. Graphenicalab appears in 1 tracked Biotech story from March 6, 2026. The tracked stories average 7 original sources each.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 18 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Graphenicalab. Shared-story counts are live from our verified record — not editorial picks.
Bioelectronic Medicine Forum
The forum convenes in NYC to discuss the future of neural interfaces.
Keynote Announcement
Iota Biosciences founder announced as the lead speaker for the NYC Forum.
Astellas Acquisition
Astellas Pharma acquires Iota Biosciences to bolster its Rx+ electronics division.
The founder of Iota Biosciences will headline the 2026 Bioelectronic Medicine Forum in New York, marking a pivotal moment for the neurotechnology sector. The event will feature a global cohort of innovators, including European firms Coherence Neuro and Graphenicalab, alongside U.S. startup Spiro Medical.
Graphenicalab is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
